PEDF regulates osteoclasts via osteoprotegerin and RANKL

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 789-794

  Akiyama, Toru ^a,b   Dass, Crispin R ^a   Shinoda, Yusuke ^b   Kawano, Hirotaka ^b   Tanaka, Sakae ^b   Choong, Peter F M ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF TOKYO   (Japan)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

OPG; Osteoclast; PEDF; RANK; RANKL

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PIGMENT EPITHELIUM DERIVED FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; HOMEOSTASIS; MALE; MOUSE; NEWBORN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; UPREGULATION;

ANIMALS; BONE RESORPTION; CELL DIFFERENTIATION; EYE PROTEINS; HUMANS; MALE; MICE; MICE, INBRED BALB C; NERVE GROWTH FACTORS; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; SERPINS;

EID: 72949093334     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.11.139     Document Type: Article

References (22)

1. Sasaki A., Alcalde R.E., Nishiyama A., Lim D.D., Mese H., Akedo H., and Matsumura T. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption. Cancer Res. 58 (1998) 462-467
2. Nakagawa M., Kaneda T., Arakawa T., Morita S., Sato T., Yomada T., Hanada K., Kumegawa M., and Hakeda Y. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett. 473 (2000) 161-164
3. Tanaka S., Nakamura K., Takahasi N., and Suda T. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol. Rev. 208 (2005) 30-49
4. Akiyama T., Bouillet P., Miyazaki T., Kadono Y., Chikuda H., Chung U.I., Fukuda A., Hikita A., Seto H., Okada T., Inaba T., Sanjay A., Baron R., Kawaguchi H., Oda H., Nakamura K., Strasser A., and Tanaka S. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J. 22 (2003) 6653-6664
5. Akiyama T., Miyazaki T., Bouillet P., Nakamura K., Strasser A., and Tanaka S. In vitro and in vivo assays for osteoclast apoptosis. Biol. Proced. Online 7 (2005) 48-59
6. Kawamura N., Kugimiya F., Oshima Y., Ohba S., Ikeda T., Saito T., Shinoda Y., Kawasaki Y., Ogata N., Hoshi K., Akiyama T., Chen W.S., Hay N., Tobe K., Kadowaki T., Azuma Y., Tanaka S., Nakamura K., Chung U.I., and Kawaguchi H. Akt1 in osteoblasts and osteoclasts controls bone remodeling. PLoS One 2 (2007) e1058
7. Julien M., Magne D., Masson M., Rolli-Derkinderen M., Chassande O., Cario-Toumaniantz C., Cherel Y., Weiss P., and Guicheux J. Phosphate stimulates matrix Gla protein expression in chondrocytes through the extracellular signal regulated kinase signaling pathway. Endocrinology 148 (2007) 530-537
8. Dass C.R., and Choong P.F. Zoledronic acid inhibits osteosarcoma growth in an orthotopic model. Mol. Cancer Ther. 6 (2007) 3263-3270
9. Tombran-Tink J., Chader G.G., and Johnson L.V. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp. Eye Res. 53 (1991) 411-414
10. Ek E.T., Dass C.R., and Choong P.F. Pigment epithelium-derived factor: a multimodal tumor inhibitor. Mol. Cancer Ther. 5 (2006) 1641-1646
11. Mundy G.R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2 (2002) 584-593
12. Quan G.M., Ojaimi J., Li Y., Kartsogiannis V., Zhou H., and Choong P.F. Localization of pigment epithelium-derived factor in growing mouse bone. Calcif. Tissue Int. 76 (2005) 146-153
13. Broadhead M.L., Dass C.R., and Choong P.F. Cancer cell apoptotic pathways mediated by PEDF: prospects for therapy. Trends Mol. Med. 15 (2009) 461-467
14. Niida S., Kaku M., Amano H., Yoshida H., Kataoka H., Nishikawa S., Tanne K., Maeda N., and Kodama H. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J. Exp. Med. 190 (1999) 293-298
15. Hiratsuka S., Minowa O., Kuno J., Noda T., and Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA 95 (1998) 9349-9354
16. Tombran-Tink J., and Barnstable C.J. Osteoblasts and osteoclasts express PEDF, VEGF-A isoforms, and VEGF receptors: possible mediators of angiogenesis and matrix remodeling in the bone. Biochem. Biophys. Res. Commun. 316 (2004) 573-579
17. Jain R.K., Safabakhsh N., Sckell A., Chen Y., Jiang P., Benjamin L., Yuan F., and Keshet E. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA 95 (1998) 10820-10825
18. Meyer C., Notari L., and Becerra S.P. Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity. J. Biol. Chem. 277 (2002) 45400-45407
19. Doll J.A., Stellmach V.M., Bouck N.P., Bergh A.R., Lee C., Abramson L.P., Cornwell M.L., Pins M.R., Borensztajn J., and Crawford S.E. Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat. Med. 9 (2003) 774-780
20. Cheung L.W., Au S.C., Cheung A.N., Ngan H.Y., Tombran-Tink J., Auersperg N., and Wong A.S. Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells. Endocrinology 147 (2006) 4179-4191
21. Cai J., Parr C., Watkins G., Jiang W.G., and Boulton M. Decreased pigment epithelium-derived factor expression in human breast cancer progression. Clin. Cancer Res. 12 (2006) 3510-3517
22. Akiyama T., Dass C.R., and Choong P.F. Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway. Mol. Cancer Ther. 7 (2008) 3461-3469